top of page

ABOUT

MYELOID

At Myeloid, we have applied our extensive knowledge of advanced gene and cell therapies to build novel platform technologies and unleash the power of myeloid cells in cancer.

​

Our proprietary ATAK™ platform is designed to designed to turn myeloid cells against tumors. These engineered cells find, recognize and penetrate tumors. These cells also prime other elements of the immune system, including T cells, thereby reinforcing the anti-tumor immune response, culminating in cancer eradication.   

AdobeStock_18058273 cube_fnl_lo.png

THE

Myeloid is powered by the discoveries of our founders – a group of world-leading scientists whose expertise spans oncology, immunology, mRNA biology, cell therapy, synthetic biology, and gene delivery.

 

We’re building a team of talented, driven scientists and other biotech industry experts to turn these discoveries into novel, life-saving treatments for people navigating life with cancer.

 

TEAM

LEADERSHIP

DarrenBaccia34_Real_lo.png
DarrenBaccia34_silhouette_lo.png

Chief Business Officer

Darren Braccia

MicheleGerber15_web_Silhouette_real_lo c
MicheleGerber15_web_Silhouettelo copy.pn

MD, MPH

Chief Medical Officer

Michele Gerber

bruce_Adjusted copy.png
bruce_Rng_silhouette.png

Chief Science Officer

Bruce McCreedy, PhD

E Jones Mar 2020_12-cutout.png
E Jones Mar 2020_12 copy.png

Board Director

Elaine Jones

PhD

TCahill1_Real_lo.png
TCahill1_Silhouette_Lo.png

President; Newpath Partners

Thomas Cahill

MD PhD

Daniel Getts_web_Silhouette_reallo copy.
Daniel Getts_web_Silhouette_lo.png

MBA, PhD

Chief Executive Officer

Daniel Getts

Yuxiao_cutout.png
yuxiao_Silhoutte copy.png

Co-Founder

Yuxiao Wang
PhD

FOUNDERS

Siddhartha-2015_Team_lo.png
Siddhartha-2015_Team_lo copy.png

MD Phil

Founder & Chair - Advisory Board

Siddhartha Mukherjee
Ronald-Vale-400x400_adjust_cutout.png
Ronald_Vale_Silhouette.png

Founder

Ronald Vale, PhD

FOUNDERS
LEADERSHIP
Daniel Getts_web_Silhouette_reallo copy.

Daniel Getts

Chief Executive Officer

BruceMcCreedy27_Adj_500px_edited.png

Bruce McCreedy, PhD

Chief Science Officer

E Jones Mar 2020_12 copy.png

Elaine Jones, PhD

Board Director

DarrenBaccia34_Real_lo.png

Darren Braccia

Chief Business Officer

SadettinOzturk12_cu_lo-600px_edited.png

Sadettin Ozturk, PhD

Chief Technology & Manufacturing Officer 

TCahill1_Real_lo_edited.png

Thomas Cahill, MD, PhD

Co-Founder and President

MicheleGerber15_web_Silhouette_real_lo copy_edited.png

Michele Gerber, MD, MPH

Chief Medical Officer

MicheleCioffi41_adj_500px_edited_edited.png

Michele Cioffi

VP, Clinical Operations

Ronald-Vale-400x400_adjust_cutout.png

Ronald Vale, PhD

Founder

Siddhartha-2015_Team_lo.png

Siddhartha Mukherjee,
MD, DPhil

Founder & Chair of Advisory Board

Yuxiao_cutout.png

Yuxiao Wang, PhD

Co-founder & Sr. Director,

Discovery Research

FOUNDERS
Ronald-Vale-400x400_adjust_cutout.png

Ronald Vale, PhD

Founder

Siddhartha-2015_Team_lo.png

Siddhartha Mukherjee,
MD, DPhil

Founder & Chair of Advisory Board

Yuxiao_cutout.png

Yuxiao Wang, PhD

Co-founder & Sr. Director,

Discovery Research

NewpathLogo_lo.png
ARE_Proprietary_Products_RGB_VentureInve
hatteraslogos-rev_new_400 copy.png
8VC-logo-black.png
INVESTORS

SCIENTIFIC ADVISORY BOARD

Clinical Cell

Therapy Advisors

Immunology, Virology & Myeloid Cell Advisors

bottom of page